IGF1 and hyperinsulinism: With the above in mind, it is suggested that, in patients with insulin resistance, the compensatory hyperinsulinemia with the concomitant increased activity of the IGF axis may explain the increase in the prevalence of thyroid and adrenal nodular disease (Figure 2).